UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6601
RUM Group Inc
RUM
$1.71B
| $55.1K | ﹤0.01% |
9,925
+6,875
| +225% | +$44.3K |
|
6602
Hennessy Advisors
HNNA
$78.4M
| $55K | ﹤0.01% |
7,724
+7,655
| +11,094% | +$54.2K |
|
6603
FVCBankcorp
FVCB
$337M
| $54.9K | ﹤0.01% |
5,032
-10,984
| -69% | -$122K |
|
6604
Velocity Financial
VEL
$719M
| $54.8K | ﹤0.01% |
3,058
-5,690
| -65% | -$100K |
|
|
GLST
6605
DELISTED
Global Star Acquisition, Inc. Class A Common Stock
GLST
| $54.6K | ﹤0.01% |
+4,913
| New | +$53.8K |
|
6606
Fidelity Momentum Factor ETF
FDMO
$950M
| $54.6K | ﹤0.01% |
857
+559
| +188% | +$33.9K |
|
6607
XBiotech
XBIT
$69.5M
| $54.6K | ﹤0.01% |
10,618
+3,274
| +45% | +$25.3K |
|
6608
FT Vest US Equity Enhance & Moderate Buffer ETF October
XOCT
$73M
| $54.5K | ﹤0.01% |
1,632
+1,568
| +2,450% | +$51.8K |
|
6609
Ponce Financial Group
PDLB
$487M
| $54.3K | ﹤0.01% |
5,944
-13,645
| -70% | -$118K |
|
6610
Castor Maritime
CTRM
$20.2M
| $54.3K | ﹤0.01% |
11,809
-2,008
| -15% | -$7.92K |
|
|
GGT
6611
Gabelli Multimedia Trust
GGT
$173M
| $54.3K | ﹤0.01% |
10,134
-5,076
| -33% | -$27.9K |
|
6612
Bausch + Lomb
BLCO
$5.84B
| $54.3K | ﹤0.01% |
3,738
-27,155
| -88% | -$408K |
|
|
IVAC
6613
DELISTED
Intevac Inc
IVAC
| $54.2K | ﹤0.01% |
14,040
-12,196
| -46% | -$48K |
|
6614
AlTi Global
ALTI
$481M
| $54.1K | ﹤0.01% |
10,386
-18,306
| -64% | -$88K |
|
6615
Noble Corporation PLC Tranche 1 Warrants
NE.WS
| $54.1K | ﹤0.01% |
2,191
-32
| -1% | -$857 |
|
6616
PharmaCyte Biotech
PMCB
$6.34M
| $54K | ﹤0.01% |
27,575
+27,566
| +306,289% | +$59.4K |
|
6617
MediWound
MDWD
$184M
| $54K | ﹤0.01% |
3,480
-109
| -3% | -$1.8K |
|
6618
Meridian
MRBK
$235M
| $53.9K | ﹤0.01% |
5,127
-569
| -10% | -$5.44K |
|
|
AIFA
6619
All In FutureTech Alliance Inc
AIFA
$10.2M
| $53.9K | ﹤0.01% |
7,073
+5,860
| +483% | +$29.5K |
|
6620
Fidelity Small-Mid Multifactor ETF
FSMD
$2.56B
| $53.9K | ﹤0.01% |
+1,430
| New | +$53.9K |
|
6621
Trevi Therapeutics
TRVI
$2.63B
| $53.7K | ﹤0.01% |
18,009
-24,109
| -57% | -$67K |
|
6622
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
$204M
| $53.6K | ﹤0.01% |
+1,485
| New | +$52.7K |
|
6623
Global Mofy Metaverse
GMM
$6.02M
| $53.5K | ﹤0.01% |
+83
| New | +$58.1K |
|
|
ACHL
6624
DELISTED
Achilles Therapeutics
ACHL
| $53.5K | ﹤0.01% |
+65,700
| New | +$57.8K |
|
6625
Innovator US Equity 5 to 15 Buffer ETF Quarterly
EALT
$171M
| $53.5K | ﹤0.01% |
1,779
+1,776
| +59,200% | +$51.5K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.